Home
About
Overview
Sharing Data
ORCID
Help
History (3)
RECIST: no longer the sharpest tool in the oncology clinical trials toolbox---point.
Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysis.
The tyranny of non-inferiority trials.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The tyranny of non-inferiority trials.
The tyranny of non-inferiority trials. Lancet Oncol. 2024 Oct; 25(10):e520-e525.
View in:
PubMed
subject areas
Clinical Trials as Topic
Cost-Benefit Analysis
Equivalence Trials as Topic
Humans
Neoplasms
Research Design
authors with profiles
Mark Ratain